HSBC Downgrades Braskem to Hold, Lowers Price Target to $1.5

Benzinga Newsdesk www.benzinga.com Negative 91.8%

Neg 91.8% Neu 0% Pos 0%

HSBC analyst Sriharsha Pappu downgrades Braskem (NYSE:BAK) from Buy to Hold and lowers the price target from $6.5 to $1.5.